These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 1421426)

  • 21. Re-expression of estrogen receptor alpha in estrogen receptor alpha-negative MCF-7 cells restores both estrogen and insulin-like growth factor-mediated signaling and growth.
    Oesterreich S; Zhang P; Guler RL; Sun X; Curran EM; Welshons WV; Osborne CK; Lee AV
    Cancer Res; 2001 Aug; 61(15):5771-7. PubMed ID: 11479214
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phosphorylated insulin-like growth factor-i/insulin receptor is present in all breast cancer subtypes and is related to poor survival.
    Law JH; Habibi G; Hu K; Masoudi H; Wang MY; Stratford AL; Park E; Gee JM; Finlay P; Jones HE; Nicholson RI; Carboni J; Gottardis M; Pollak M; Dunn SE
    Cancer Res; 2008 Dec; 68(24):10238-46. PubMed ID: 19074892
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progestins and antiprogestins in mammary tumour growth and metastasis.
    Shi YE; Liu YE; Lippman ME; Dickson RB
    Hum Reprod; 1994 Jun; 9 Suppl 1():162-73. PubMed ID: 7962461
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Affinity for the insulin-like growth factor-II (IGF-II) receptor inhibits autocrine IGF-II activity in MCF-7 breast cancer cells.
    Ellis MJ; Leav BA; Yang Z; Rasmussen A; Pearce A; Zweibel JA; Lippman ME; Cullen KJ
    Mol Endocrinol; 1996 Mar; 10(3):286-97. PubMed ID: 8833657
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A dominant negative mutant of the insulin-like growth factor-I receptor inhibits the adhesion, invasion, and metastasis of breast cancer.
    Dunn SE; Ehrlich M; Sharp NJ; Reiss K; Solomon G; Hawkins R; Baserga R; Barrett JC
    Cancer Res; 1998 Aug; 58(15):3353-61. PubMed ID: 9699666
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progesterone crosstalks with insulin-like growth factor signaling in breast cancer cells via induction of insulin receptor substrate-2.
    Cui X; Lazard Z; Zhang P; Hopp TA; Lee AV
    Oncogene; 2003 Oct; 22(44):6937-41. PubMed ID: 14534541
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin-like growth factor receptor expression and function in human breast cancer.
    Cullen KJ; Yee D; Sly WS; Perdue J; Hampton B; Lippman ME; Rosen N
    Cancer Res; 1990 Jan; 50(1):48-53. PubMed ID: 2152773
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The expression and role of hybrid insulin/insulin-like growth factor receptor type 1 in endometrial carcinoma cells.
    Zhang G; Li X; Zhang L; Zhao L; Jiang J; Wang J; Wei L
    Cancer Genet Cytogenet; 2010 Jul; 200(2):140-8. PubMed ID: 20620597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The activated insulin-like growth factor I receptor induces depolarization in breast epithelial cells characterized by actin filament disassembly and tyrosine dephosphorylation of FAK, Cas, and paxillin.
    Guvakova MA; Surmacz E
    Exp Cell Res; 1999 Aug; 251(1):244-55. PubMed ID: 10438590
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progestin regulation of estrogen receptor messenger RNA in human breast cancer cells.
    Alexander IE; Shine J; Sutherland RL
    Mol Endocrinol; 1990 Jun; 4(6):821-8. PubMed ID: 2233741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Down-regulation of type I insulin-like growth factor receptor increases sensitivity of breast cancer cells to insulin.
    Zhang H; Pelzer AM; Kiang DT; Yee D
    Cancer Res; 2007 Jan; 67(1):391-7. PubMed ID: 17210722
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.
    Sachdev D; Li SL; Hartell JS; Fujita-Yamaguchi Y; Miller JS; Yee D
    Cancer Res; 2003 Feb; 63(3):627-35. PubMed ID: 12566306
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In IGF-I receptor-deficient leiomyosarcoma cells autocrine IGF-II induces cell invasion and protection from apoptosis via the insulin receptor isoform A.
    Sciacca L; Mineo R; Pandini G; Murabito A; Vigneri R; Belfiore A
    Oncogene; 2002 Nov; 21(54):8240-50. PubMed ID: 12447687
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin receptor substrates mediate distinct biological responses to insulin-like growth factor receptor activation in breast cancer cells.
    Byron SA; Horwitz KB; Richer JK; Lange CA; Zhang X; Yee D
    Br J Cancer; 2006 Nov; 95(9):1220-8. PubMed ID: 17043687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of mitogen-activated protein kinase kinase selectively inhibits cell proliferation in human breast cancer cells displaying enhanced insulin-like growth factor I-mediated mitogen-activated protein kinase activation.
    Hermanto U; Zong CS; Wang LH
    Cell Growth Differ; 2000 Dec; 11(12):655-64. PubMed ID: 11149601
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New insights in the molecular mechanism of progestin-induced proliferation of mammary epithelium: induction of the local biosynthesis of growth hormone (GH) in the mammary glands of dogs, cats and humans.
    Mol JA; van Garderen E; Rutteman GR; Rijnberk A
    J Steroid Biochem Mol Biol; 1996 Jan; 57(1-2):67-71. PubMed ID: 8645618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tamoxifen interferes with the insulin-like growth factor I receptor (IGF-IR) signaling pathway in breast cancer cells.
    Guvakova MA; Surmacz E
    Cancer Res; 1997 Jul; 57(13):2606-10. PubMed ID: 9205064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Progestin regulation of epidermal growth factor receptor in human mammary carcinoma cells.
    Murphy LJ; Sutherland RL; Stead B; Murphy LC; Lazarus L
    Cancer Res; 1986 Feb; 46(2):728-34. PubMed ID: 3000583
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Paracrine interaction in co-culture of hormone-dependent and independent breast cancer cells.
    Cappelletti V; Ruedl C; Miodini P; Fioravanti L; Coradini D; Di Fronzo G; Silvestrini R
    Breast Cancer Res Treat; 1993; 26(3):275-81. PubMed ID: 8251652
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Progestins and their effects on the breast.
    Druckmann R
    Maturitas; 2003 Dec; 46 Suppl 1():S59-69. PubMed ID: 14670647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.